InBioGen Co Ltd
KRX:101140
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
InBioGen Co Ltd
Revenue
InBioGen Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
InBioGen Co Ltd
KRX:101140
|
Revenue
₩6.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-3%
|
|
|
Hwaseung Enterprise Co Ltd
KRX:241590
|
Revenue
₩1.6T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Hwaseung Industries Co Ltd
KRX:006060
|
Revenue
₩1.8T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
InBioGen Co Ltd
Glance View
INBIOGEN CO., Ltd. engages in the manufacture and sale of footwear products. The company is headquartered in Seoul, Seoul and currently employs 56 full-time employees. The company went IPO on 2008-04-02. The firm operates its business through four segments. The Kiosk Business segment is engaged in the operation of unmanned payment machine business in restaurants, karaoke rooms, and personal computer (PC) rooms. The Footwear Business segment is mainly engaged in the sale of children's shoes and adult shoes. The Wood Pellet Business segment mainly sells wood pellets and sawdust. The Other Business segment engages in online and offline education business to foster human resources in the FinTech service, platform business, and block chain industry.
See Also
What is InBioGen Co Ltd's Revenue?
Revenue
6.3B
KRW
Based on the financial report for Dec 31, 2025, InBioGen Co Ltd's Revenue amounts to 6.3B KRW.
What is InBioGen Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
-3%
Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for InBioGen Co Ltd have been -15% over the past three years , -9% over the past five years , and -3% over the past ten years .
